Additional file 1 of Results of a non-randomized, open-label phase I study evaluating the novel immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa

Figshare 2026 Open access

Read full text
Authors: Karl Wallblom, K Holmgren, Sigrid Lundgren, Emma Belfrage, Torborg Hoppe, Matilda Hugerth, Anna-Karin Lindqvist, Enikö Sonkoly, Artur Schmidtchen
DOI: 10.6084/m9.figshare.31015535
Cited by: 0

Fields of Study & Subjects

Skin and Cellular Biology Research Autoimmune Bullous Skin Diseases Sympathectomy and Hyperhidrosis Treatments

Publication details

Journal / source
Figshare
Publication date
1 January 2026